AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2018
Feb 13, 2018
33298_dirs_2018-02-12_7b5e79d7-d76e-44f4-a567-e27ae3e39eff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2018-02-08
Reporting Person: Schreiber Justin (Director, President, Immudyne PR, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-08 | Common Stock, par value $0.01 | P | 600000 | $0.23 | Acquired | 2618693 | Indirect |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17